(EXO) Exor - Overview

Sector: Industrials | Industry: Farm & Heavy Construction Machinery | Exchange: AS (Netherlands) | Market Cap: 21.923m EUR | Total Return: -24.6% in 12m

Automobiles, Farming Equipment, Healthcare Technology, Media, Sports Teams
Total Rating 38
Safety 26
Buy Signal -0.17
Farm & Heavy Construction Machinery
Industry Rotation: -3.1
Market Cap: 25.5B
Avg Turnover: 12.2M
Risk 3d forecast
Volatility21.3%
VaR 5th Pctl3.79%
VaR vs Median7.72%
Reward TTM
Sharpe Ratio-1.12
Rel. Str. IBD14
Rel. Str. Peer Group32.6
Character TTM
Beta0.655
Beta Downside0.793
Hurst Exponent0.533
Drawdowns 3y
Max DD39.28%
CAGR/Max DD-0.15
CAGR/Mean DD-0.45
EPS (Earnings per Share) EPS (Earnings per Share) of EXO over the last years for every Quarter: "2021-03": -5.12, "2021-06": null, "2021-09": null, "2021-12": null, "2022-03": 1.32, "2022-06": 5.68, "2022-09": 0, "2022-12": null, "2023-03": 6.86, "2023-06": 0, "2023-09": 0, "2023-12": 16.1, "2024-03": 0, "2024-06": 0, "2024-09": 0, "2024-12": -0.11, "2025-06": -3.01, "2025-12": -15.2628,
EPS CAGR: -78.28%
EPS Trend: -38.3%
Last SUE: -0.27
Qual. Beats: 0
Revenue Revenue of EXO over the last years for every Quarter: 2021-03: 8070, 2021-06: 16140, 2021-09: 8738.5, 2021-12: 17477, 2022-03: 9341.5, 2022-06: 18683, 2022-09: 11580.5, 2022-12: 23161, 2023-03: 10683.5, 2023-06: 21367, 2023-09: 11687.5, 2023-12: 23375, 2024-03: null, 2024-06: 15140, 2024-09: null, 2024-12: 255, 2025-06: -557, 2025-12: -3034,
Rev. CAGR: -46.64%
Rev. Trend: -60.8%
Last SUE: 0.07
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: EXO Exor

Exor N.V. is a diversified holding company headquartered in the Netherlands, controlled by the Agnelli family. Its portfolio spans several capital-intensive industries, most notably the automotive sector through significant stakes in Ferrari and Stellantis. Beyond transportation, the firm maintains interests in agricultural machinery via CNH Industrial, luxury goods through Christian Louboutin, and professional sports via Juventus FC.

The company operates under a family-office investment model, focusing on long-term capital appreciation by acquiring large minority or controlling stakes in global market leaders. This structure allows Exor to navigate cyclical downturns in the automotive and construction sectors by diversifying into media, healthcare technology, and data analytics. Investors often evaluate Exor based on its Net Asset Value (NAV) relative to its market capitalization, a common metric for European investment holding companies.

Detailed performance metrics and historical valuation trends for these holdings are available on ValueRay for those conducting further analysis. Exor remains a key vehicle for exposure to European industrial engineering and global luxury branding.

Headlines to Watch Out For
  • Ferrari equity performance drives net asset value and investor sentiment
  • Stellantis production volume and global automotive demand impact core earnings
  • Philips healthcare segment recovery influences long-term industrial investment returns
  • CNH Industrial and Iveco Group performance dictates capital allocation strategy
  • Discount to Net Asset Value remains primary driver of share price appreciation
Piotroski VR‑10 (Strict) 7.0
Net Income: 10.88b TTM > 0 and > 6% of Revenue
FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.40 > 1.0
NWC/Revenue: 7.17% < 20% (prev 53.27%; Δ -46.11% < -1%)
CFO/TA 0.08 > 3% & CFO 2.91b > Net Income 10.88b
Net Debt (2.15b) to EBITDA (16.93b): 0.13 < 3
Current Ratio: 2.21 > 1.5 & < 3
Outstanding Shares: last quarter (207.6m) vs 12m ago -7.96% < -2%
Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin)
Asset Turnover: 17.90% > 50% (prev 70.81%; Δ -52.91% > 0%)
Interest Coverage Ratio: 72.00 > 6 (EBITDA TTM 16.93b / Interest Expense TTM 213.0m)
Altman Z'' 10.00
A: 0.02 (Total Current Assets 1.55b - Total Current Liabilities 701.0m) / Total Assets 37.13b
B: -0.02 (Retained Earnings -624.0m / Total Assets 37.13b)
C: 0.23 (EBIT TTM 15.34b / Avg Total Assets 65.95b)
D: 8.55 (Book Value of Equity 33.24b / Total Liabilities 3.89b)
Altman-Z'' Score: 10.63 = AAA
What is the price of EXO shares? As of May 20, 2026, the stock is trading at EUR 65.80 with a total of 170,957 shares traded.
Over the past week, the price has changed by -0.30%, over one month by -6.27%, over three months by -9.49% and over the past year by -24.62%.
Is EXO a buy, sell or hold? Exor has no consensus analysts rating.
What are the forecasts/targets for the EXO price?
Analysts Target Price - -
Exor (EXO) - Fundamental Data Overview as of 16 May 2026
Market Cap USD = 25.49b (21.92b EUR * 1.1626 EUR.USD)
P/S = 1.7692
P/B = 0.4164
Revenue TTM = 11.80b EUR
EBIT TTM = 15.34b EUR
EBITDA TTM = 16.93b EUR
 Long Term Debt = unknown (none)
 Short Term Debt = 629.0m EUR (from shortTermDebt, two quarters ago)
Debt = 3.54b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 2.15b EUR (recalculated: Debt 3.54b - CCE 1.39b)
Enterprise Value = 24.08b EUR (21.92b + Debt 3.54b - CCE 1.39b)
Interest Coverage Ratio = 72.00 (Ebit TTM 15.34b / Interest Expense TTM 213.0m)
EV/FCF = 8.27x (Enterprise Value 24.08b / FCF TTM 2.91b)
FCF Yield = 12.09% (FCF TTM 2.91b / Enterprise Value 24.08b)
FCF Margin = 24.65% (FCF TTM 2.91b / Revenue TTM 11.80b)
Net Margin = 92.16% (Net Income TTM 10.88b / Revenue TTM 11.80b)
 Gross Margin = unknown ((Revenue TTM 11.80b - Cost of Revenue TTM 20.0m) / Revenue TTM)
 Tobins Q-Ratio = 0.65 (Enterprise Value 24.08b / Total Assets 37.13b)
Interest Expense / Debt = 2.15% (Interest Expense 76.0m / Debt 3.54b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 11.50b (EBIT 15.34b * (1 - 25.00%))
Current Ratio = 2.21 (Total Current Assets 1.55b / Total Current Liabilities 701.0m)
Debt / Equity = 0.11 (Debt 3.54b / totalStockholderEquity, last quarter 33.24b)
Debt / EBITDA = 0.13 (Net Debt 2.15b / EBITDA 16.93b)
Debt / FCF = 0.74 (Net Debt 2.15b / FCF TTM 2.91b)
Total Stockholder Equity = 36.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.49% (Net Income 10.88b / Total Assets 37.13b)
RoE = 29.77% (Net Income TTM 10.88b / Total Stockholder Equity 36.54b)
RoCE = 42.10% (EBIT 15.34b / Capital Employed (Total Assets 37.13b - Current Liab 701.0m))
RoIC = 28.49% (NOPAT 11.50b / Invested Capital 40.38b)
WACC = 7.36% (E(21.92b)/V(25.46b) * Re(8.29%) + D(3.54b)/V(25.46b) * Rd(2.15%) * (1-Tc(0.25)))
Discount Rate = 8.29% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -88.66 | Cagr: -5.29%
[DCF] Terminal Value 83.71% ; FCFF base≈3.81b ; Y1≈4.70b ; Y5≈8.01b
[DCF] Fair Price = 773.3 (EV 158.54b - Net Debt 2.15b = Equity 156.39b / Shares 202.2m; r=7.36% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -38.35 | EPS CAGR: -78.28% | SUE: -0.27 | # QB: 0
Revenue Correlation: -60.80 | Revenue CAGR: -46.64% | SUE: 0.07 | # QB: 0
EPS current Year (2026-12-31): EPS=2.21 | Chg30d=+163.29% | Revisions=+20% | GrowthEPS=-10.5% | GrowthRev=+0.0%
EPS next Year (2027-12-31): EPS=1.26 | Chg30d=-47.82% | Revisions=-20% | GrowthEPS=-42.8% | GrowthRev=+0.0%